DOI QR코드

DOI QR Code

Simple synthesis of [11C]DASB in HPLC loop and small animal PET imaging study

  • Lee, Boeun (Department of Nuclear Medicine, Institute of Radiation Medicine, Seoul National University College of Medicine) ;
  • Cho, Yong-Hyun (Department of Nuclear Medicine, Seoul National University Hospital) ;
  • Lee, Yun-Sang (Department of Nuclear Medicine, Institute of Radiation Medicine, Seoul National University College of Medicine) ;
  • Jeong, Jae Min (Department of Nuclear Medicine, Institute of Radiation Medicine, Seoul National University College of Medicine)
  • Received : 2016.10.27
  • Accepted : 2016.12.12
  • Published : 2016.12.30

Abstract

As a neurotransmitter, serotonin plays important roles in brain. It relates various neuropsychiatric disorders such as anxiety, depression, schizophrenia. [$^{11}C$]DASB is a well-known PET tracer for serotonin transporter imaging. In this study, we synthesized [$^{11}C$]DASB in HPLC loop for simple and rapid production. Total synthesis time was about 40 minutes and the radiochemical purities were over 99%. The specific activity was $51.4GBq/{\mu}mole$ (n=16). [$^{11}C$]DASB showed highest uptake in mid-brain that serotonergic nerves are abundant and lowest uptake in cerebellum. In conclusion, we used HPLC loop method for [$^{11}C$]DASB labeling and this method is useful for production of $^{11}C$ labeled PET tracers.

Keywords

References

  1. Owens MJ, Nemeroff CB. Role of Serotonin in the Pathophysiology of Depression - Focus on the Serotonin Transporter. Clin Chem. 1994;40:288-295.
  2. Holmes A, Murphy DL, Crawley JN. Abnormal behavioral phenotypes of serotonin transporter knockout mice: Parallels with human anxiety and depression. Biol Psychiat. 2003;54:953-959. https://doi.org/10.1016/j.biopsych.2003.09.003
  3. Spies M, Knudsen GM, Lanzenberger R, Kasper S. The serotonin transporter in psychiatric disorders: insights from PET imaging. Lancet Psychiat. 2015;2:743-755. https://doi.org/10.1016/S2215-0366(15)00232-1
  4. Assal F, Alarcon M, Solomon EC, Masterman D, Geschwind DH, Cummings JL. Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease. Arch Neurol. 2004;61:1249-1253.
  5. Hariri AR, Holmes A. Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn Sci. 2006;10:182-191. https://doi.org/10.1016/j.tics.2006.02.011
  6. Seo JS, Min KJ, Kim W, Seok JH, Bahk WM, Song HC. Korean medication algorithm for depressive disorder 2006(I). Eur Neuropsychopharm. 2007;17:S314-S315.
  7. Davidson JR, Zhang W, Connor KM, Ji J, Jobson K, Lecrubier Y, McFarlane AC, Newport DJ, Nutt DJ, Osser DN, Stein DJ, Stowe ZN, Tajima O, Versiani M. A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD). Journal of Psychopharmacology. 2010;24:3-26. https://doi.org/10.1177/0269881108096505
  8. Katzman M. Clinical practice guidelines: Management of anxiety disorders. Can J Psychiat. 2006;51:1S-92S. https://doi.org/10.1177/070674370605100101
  9. Hiemke C, Hartter S. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther. 2000;85:11-28. https://doi.org/10.1016/S0163-7258(99)00048-0
  10. Harvey AT, Preskorn SH. Cytochrome p450 enzymes: Interpretation of their interactions with selective serotonin reuptake inhibitors .1. J Clin Psychopharm. 1996;16:273-285. https://doi.org/10.1097/00004714-199608000-00002
  11. Wilson AA, Ginovart N, Schmidt M, Meyer JH, Threlkeld PG, Houle S. Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of $^{11}C$-labeled 2-(phenylthio)araalkylamines. J Med Chem. 2000;43:3103-3110. https://doi.org/10.1021/jm000079i
  12. Ginovart N, Wilson AA, Meyer JH, Hussey D, Houle S. [$^{11}C$]DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats. Synapse. 2003;47:123-133. https://doi.org/10.1002/syn.10155
  13. Wilson AA, Garcia A, Jin L, Houle S. Radiotracer synthesis from[$^{11}C$]-iodomethane: a remarkably simple captive solvent method. Nucl Med Biol. 2000;27:529-532. https://doi.org/10.1016/S0969-8051(00)00132-3
  14. Lee HJ, Jeong JM, Lee Y-S, Kim HW, Choi JY, Lee DS, Chung J-K, Lee MC. A Convenient Radiolabeling of [$^{11}C$] (R)-PK11195 Using Loop Method in Automatic Synthesis Module. Nucl Med Mol Imaging. 2009;43:337-343.
  15. Shao X, Schnau PL, Fawaz MV, Scott PJ. Enhanced radiosyntheses of [$^{11}C$]raclopride and [$^{11}C$]DASB using ethanolic loop chemistry. Nucl Med Biol. 2013;40:109-116. https://doi.org/10.1016/j.nucmedbio.2012.09.008
  16. Ungersboeck J, Philippe C, Haeusler D, Mitterhauser M, Lanzenberger R, Dudczak R, Wadsak W. Optimization of [$^{11}C$]DASB-synthesis: vessel-based and flow-through microreactor methods. Appl Radiat Isot. 2012;70:2615-2620. https://doi.org/10.1016/j.apradiso.2012.08.001
  17. Larsen P, Ulin J, Dahlstrom K, Jensen M. Synthesis of [$^{11}C$] iodomethane by iodination of [$^{11}C$]methane. Appl Radiat Isotopes. 1997;48:153-157. https://doi.org/10.1016/S0969-8043(96)00177-7
  18. Houle S, Ginovart N, Hussey D, Meyer JH, Wilson AA. Imaging the serotonin transporter with positron emission tomography: initial human studies with [$^{11}C$]DAPP and [$^{11}C$]DASB. Eur J Nucl Med. 2000;27:1719-1722. https://doi.org/10.1007/s002590000365
  19. Ginovart N, Wilson AA, Meyer JH, Hussey D, Houle S. Positron emission tomography quantification of [$^{11}C$]-DASB binding to the human serotonin transporter: modeling strategies. J Cereb Blood Flow Metab. 2001;21:1342-1353. https://doi.org/10.1097/00004647-200111000-00010